Prostate cancer

J Urol. 1996 Jan;155(1):226-7. doi: 10.1016/s0022-5347(01)66600-x.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Androgen Antagonists / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Chemotherapy, Adjuvant
  • Flutamide / adverse effects
  • Flutamide / therapeutic use
  • Humans
  • Male
  • Obesity / epidemiology
  • Prognosis
  • Prostate-Specific Antigen / blood
  • Prostatectomy / adverse effects
  • Prostatic Neoplasms* / mortality
  • Prostatic Neoplasms* / therapy
  • Urethral Stricture / etiology
  • Urethral Stricture / therapy

Substances

  • Androgen Antagonists
  • Antineoplastic Agents
  • Flutamide
  • Prostate-Specific Antigen